Gene Engineering Technology
GE Healthcare Dharmacon released over one million new CRISPR-Cas9 gene editing products. They use an advanced algorithm to create and explore highly functional and specific reagents. The experiments were conducted on rats and mouth but these agents are also targeted on human beings. The new agents includ: pre-designed synthetic CRISPR RNAs (crRNAs); single guide RNA…
Read more...